NCT07034131Not yet recruiting
Evaluation of Osteo-Buddy in Improving Osteoporosis Knowledge
Improving Both Health in Women With the Use of Osteo-Buddy to Enhance Osteoporosis Knowledge - A Mixed Method Clinical Trial
Source: ClinicalTrials.gov · Last updated 1 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is a pilot randomised controlled trial (RCT) to evaluate the use of a Virtual Health Assistant (VHA) named Osteo-Buddy in improving the knowledge of osteoporosis in older women.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- First submitted
- 13 Jun 2025
- Start date
- Jul 2025
- Primary completion date
- Mar 2026
- Lead sponsor
- SingHealth Polyclinics
- Diseases
- Osteoporosis
- NCT number
- NCT07034131
What you commit to
- Study type: Interventional
- Planned participants: 80
- From Jul 2025 to the primary completion date, Mar 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Known terminal illness
- Visual, hearing and/or cognitive impairment or mental illness that renders them unable to provide informed consent
Who the study is looking for
- Age 50 and above
- Medium or high Osteoporosis Self-Assessment Tool for Asians (OSTA) score
- Not undertaken Bone Mineral Density (BMD) scan
- Never been treated with anti-osteoporosis medications such as bisphosphonates (e.g. alendronate, risendronate, ibandronate, zolendronate, pamidronate) or denosumab
- Able to read and speak English
- Currently use and own a smartphone where Osteo-Buddy can be used
Age in the registry: 50 years to - · Sex: Female · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.